检索结果 - Dalia Ercan

Refine Results
  1. 1
    Discovery of selective irreversible inhibitors for EGFR-T790M

    Discovery of selective irreversible inhibitors for EGFR-T790M 由 Wenjun Zhou, Dalia Ercan, Pasi A. Jänne, Nathanael S. Gray

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines

    Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines 由 Antonio Calles, Nicholas Kwiatkowski, Bernard K. Cammarata, Dalia Ercan, Nathanael S. Gray, Pasi A. Jänne

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors

    EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors 由 Dalia Ercan, Hwan Geun Choi, Cai‐Hong Yun, Marzia Capelletti, Ting Xie, Michael J. Eck, Nathanael S. Gray, Pasi A. Jänne

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway

    Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway 由 Alexis B. Cortot, Claire E. Repellin, Takeshi Shimamura, Marzia Capelletti, Kreshnik Zejnullahu, Dalia Ercan, James G. Christensen, Kwok‐Kin Wong, Nathanael S. Gray, Pasi A. Jänne

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i>-Mutant Lung Cancer

    Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in <i>EGFR</i>-Mutant Lung Cancer 由 Erin M. Tricker, Chunxiao Xu, Sharmeen Uddin, Marzia Capelletti, Dalia Ercan, Atsuko Ogino, Christine A. Pratilas, Neal Rosen, Nathanael S. Gray, Kwok‐Kin Wong, Pasi A. Jänne

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Identification of Existing Drugs That Effectively Target <i>NTRK1</i> and <i>ROS1</i> Rearrangements in Lung Cancer

    Identification of Existing Drugs That Effectively Target <i>NTRK1</i> and <i>ROS1</i> Rearrangements in Lung Cancer 由 Curtis R. Chong, Magda Bahcall, Marzia Capelletti, Takayuki Kosaka, Dalia Ercan, Taebo Sim, Lynette M. Sholl, Mizuki Nishino, Bruce E. Johnson, Nathanael S. Gray, Pasi A. Jänne

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Combined EGFR/MET or EGFR/HSP90 Inhibition Is Effective in the Treatment of Lung Cancers Codriven by Mutant EGFR Containing T790M and MET

    Combined EGFR/MET or EGFR/HSP90 Inhibition Is Effective in the Treatment of Lung Cancers Codriven by Mutant EGFR Containing T790M and MET 由 Lu Xu, Eiki Kikuchi, Chunxiao Xu, Hiromichi Ebi, Dalia Ercan, Katherine A. Cheng, Robert F. Padera, Jeffrey A. Engelman, Pasi A. Jänne, Geoffrey I. Shapiro, Takeshi Shimamura, Kwok‐Kin Wong

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor

    Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor 由 Dalia Ercan, Kreshnik Zejnullahu, Kimio Yonesaka, Yun Xiao, Marzia Capelletti, Andrew M. Rogers, Eugene Lifshits, Alyssa Brown, Charles Lee, James G. Christensen, David J. Kwiatkowski, Jeffrey A. Engelman, Pasi A. Jänne

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

    Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M 由 Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip, Byoung Chul Cho, Daniel Stetson, Brian Dougherty, Zhongwu Lai, Aleksandra Markovets, Ana Vivancos, Yanan Kuang, Dalia Ercan, Sarah E Matthews, Mireille Cantarini, J. Carl Barrett, Pasi A. Jänne, Geoffrey R. Oxnard

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Pharmacological targeting of the pseudokinase Her3

    Pharmacological targeting of the pseudokinase Her3 由 Ting Xie, Sang Min Lim, Kenneth D. Westover, Michael Dodge, Dalia Ercan, Scott B. Ficarro, Durga Udayakumar, Deepak Gurbani, Hyun Seop Tae, Steven M. Riddle, Taebo Sim, Jarrod A. Marto, Pasi A. Jänne, Craig M. Crews, Nathanael S. Gray

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors

    Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors 由 Takayuki Kosaka, Junko Tanizaki, Raymond M. Paranal, Hideki Endoh, Christine Lydon, Marzia Capelletti, Claire E. Repellin, Jihyun Choi, Atsuko Ogino, Antonio Calles, Dalia Ercan, Amanda J. Redig, Magda Bahcall, Geoffrey R. Oxnard, Michael J. Eck, Pasi A. Jänne

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

    Novel mutant-selective EGFR kinase inhibitors against EGFR T790M 由 Wenjun Zhou, Dalia Ercan, Liang Chen, Cai‐Hong Yun, Danan Li, Marzia Capelletti, Alexis B. Cortot, Lucian R. Chirieac, Roxana E. Iacob, Robert F. Padera, John R. Engen, Kwok‐Kin Wong, Michael J. Eck, Nathanael S. Gray, Pasi A. Jänne

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Identification of Recurrent <i>FGFR3–TACC3</i> Fusion Oncogenes from Lung Adenocarcinoma

    Identification of Recurrent <i>FGFR3–TACC3</i> Fusion Oncogenes from Lung Adenocarcinoma 由 Marzia Capelletti, Michael Dodge, Dalia Ercan, Peter S. Hammerman, Seung-Il Park, Young Tae Kim, Hidefumi Sasaki, David M. Jablons, Doron Lipson, Lauren Young, Phil Stephens, Vincent A. Miller, Neal I. Lindeman, Kiara J. Munir, William G. Richards, Pasi A. Jänne

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

    Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors 由 Li Tan, Jun Wang, Junko Tanizaki, Zhifeng Huang, Amir Reza Aref, Maria Rusan, Su-Jie Zhu, Yiyun Zhang, Dalia Ercan, Rachel G. Liao, Marzia Capelletti, Wenjun Zhou, Wooyoung Hur, Namdoo Kim, Taebo Sim, Suzanne Gaudet, David A. Barbie, Jing-Ruey Joanna Yeh, Cai-Hong Yun, Peter S. Hammerman, Moosa Mohammadi, Pasi A. Jänne, Nathanael S. Gray

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors

    Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors 由 Dalia Ercan, Chunxiao Xu, Masahiko Yanagita, Calixte S. Monast, Christine A. Pratilas, Joan Montero, Mohit Butaney, Takeshi Shimamura, Lynette M. Sholl, Elena Ivanova, Madhavi Tadi, Andrew M. Rogers, Claire E. Repellin, Marzia Capelletti, Ophélia Maertens, Eva M. Goetz, Anthony Letai, Levi A. Garraway, Matthew J. Lazzara, Neal Rosen, Nathanael S. Gray, Kwok‐Kin Wong, Pasi A. Jänne

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors

    A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors 由 Takaaki Sasaki, Jussi Koivunen, Atsuko Ogino, Masahiko Yanagita, Sarah Nikiforow, Wei Zheng, Christopher S. Lathan, Judith Marcoux, Jinyan Du, Katsuhiro Okuda, Marzia Capelletti, Takeshi Shimamura, Dalia Ercan, Magda Stumpfova, Yun Xiao, Stanislawa Weremowicz, Mohit Butaney, Stéphanie Héon, Keith D. Wilner, James G. Christensen, Michel J. Eck, Kwok‐Kin Wong, Neal I. Lindeman, Nathanael S. Gray, Scott J. Rodig, Pasi A. Jänne

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR

    Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR 由 Qingsong Liu, Chunxiao Xu, Sivapriya Kirubakaran, Xin Zhang, Wooyoung Hur, Yan Liu, Nicholas Kwiatkowski, Jinhua Wang, Kenneth D. Westover, Peng Gao, Dalia Ercan, Mario Niepel, Carson C. Thoreen, Seong A. Kang, Matthew P. Patricelli, Yuchuan Wang, Tanya Tupper, Abigail Altabef, Hidemasa Kawamura, Kathryn D. Held, Danny M. Chou, Stephen J. Elledge, Pasi A. Jänne, Kwok‐Kin Wong, David M. Sabatini, Nathanael S. Gray

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors

    Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors 由 Yong Jia, Cai‐Hong Yun, Eunyoung Park, Dalia Ercan, Mari Manuia, Jose Juarez, Chunxiao Xu, Kevin Rhee, Ting Chen, Haikuo Zhang, Sangeetha Palakurthi, Jaebong Jang, G. Lelais, Michael DiDonato, Badry Bursulaya, Pierre‐Yves Michellys, Robert Epple, Thomas H. Marsilje, Matthew McNeill, Wenshuo Lu, Jennifer L. Harris, Steven L. Bender, Kwok‐Kin Wong, Pasi A. Jänne, Michael J. Eck

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

    Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer 由 Aria Vaishnavi, Marzia Capelletti, Anh T. Le, Severine Kako, Mohit Butaney, Dalia Ercan, Sakshi Mahale, Kurtis D. Davies, Dara L. Aisner, Amanda B. Pilling, Eamon M. Berge, Young Tae Kim, Hidefumi Sasaki, Seung-Il Park, Gregory V. Kryukov, Levi A. Garraway, Peter S. Hammerman, Julia Haas, Steven W. Andrews, Doron Lipson, Philip J. Stephens, V.A. Miller, Marileila Varella‐Garcia, Pasi A. Jänne, Robert C. Doebele

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab

    Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab 由 Kimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, Taroh Satoh, Federico Cappuzzo, John Souglakos, Dalia Ercan, Andrew M. Rogers, Massimo Roncalli, Masayuki Takeda, Yasuhito Fujisaka, Juliet Philips, Toshio Shimizu, Osamu Maenishi, Yong Gon Cho, Jason Sun, Annarita Destro, Koichi Taira, Koji Takeda, Takafumi Okabe, Jeffrey Swanson, Ito H, Minoru Takada, Eugene Lifshits, Kiyotaka Okuno, Jeffrey A. Engelman, Ramesh A. Shivdasani, Kazuto Nishio, Masahiro Fukuoka, Marileila Varella‐Garcia, Kazuhiko Nakagawa, Pasi A. Jänne

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: